期刊文献+

大鼠胸腺素β4基因重组慢病毒载体的构建及体外表达

Construction and expression in vitro of the recombinant lentiviral vector containing the rat thymosin beta 4 gene
原文传递
导出
摘要 目的构建大鼠胸腺素β4(Tβ4)基因的重组慢病毒载体,转染293T细胞并观察Tp4的表达。方法从Genbank获取大鼠TB4基因序列,化学合成后连接人线性化慢病毒载体pGC—FU,得到重组慢病毒载体pGC—FU—T[34,将其转化细菌感受态细胞后行菌落聚合酶链反应(PCR)鉴定,对PCR鉴定阳性的克隆进行测序鉴定。pGC—FU—T134、pHeIper1.0、pHelper2.0共转293T细胞,收集上清液浓缩后使用实时定量PCR(Real—timePCR)进行滴度检测。用所得病毒感染293T细胞后,Westernblot检测TB4表达。结果目的基因质粒酶切后琼脂糖凝胶电泳图谱示酶切片段大小为143bp;菌落PCR结果示阴性转化子得到198bp片段,阳性转化子得到333bp片段;测序结果与预期相符合;Real—timePCR示所得病毒滴度约为2×109TU;Westernblot示T134转染组在33KD处有特征条带。结论成功构建大鼠T134基凶慢病毒载体pGC—FU—T[34,并建立慢病毒过表达系统: Objective To construct the recombinant lentiviral vector over-expressing the rat thy- mosin beta 4 (Tβ4) gene, to observe its expression in 293T cells, and to provide an experimental founda- tion for the treatment of myocardial infarction at the gene level. Methods The rat Tβ4 gene was obtained from genbank, and connected into the linearized lentiviral vector to generate the lentiviral over-expressing vector named pGC-FU-Tβ4. The positive clones identified by polymerase chain reaction (PCR) were se- quenced after they was transformed into bacterial competent ceils. The concentrated supernatants were col- lected for titer measurement by using Real-time PCR after pGC-FU-Tβ4, pHeIperl. 0, and pHelper2.0 were co-transfected into 293T cells. The Tβ4 was detected by using Western blotting after transfecting the 293T cells with the acquired reeombinant lentivirus. Results A target gene fragment of 143 bp was ob- tained by enzyme digestion. The negative transformants of 198 bp and the positive transformants of 333 bp were obtained by PCR. The sequencing results were consistent with the expectation. The titer of concentrat- ed lentivirus reached 2 × 109 TU/ml. A characteristic band of 33 KD could be found. Conclusion The re- combinant lentiviral vector of the rat Tβ4 was successfully constructed and packaged, which laid the foun- dation for further application of the Tβ4 to the treatment of myocardial infarction at the gene level.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第8期1463-1465,共3页 Chinese Journal of Experimental Surgery
基金 武汉晨光计划资助项目(200950431177)
关键词 胸腺素β4基因 慢病毒载体 心肌梗死 Thymosin beta 4 gene Lentiviral vector Myocardial infarction
  • 相关文献

参考文献14

  • 1Eun LY, Song BW, Cha MJ,et al. Overexpression of phosphoinositide- 3-kinase class II alpha enhances mesenchymal stem cell survival in infracted myocardium. Biochem Biophys Res Commun, 2010,402: 272-279.
  • 2Crockford D, Turjman N, Allan C, et al. Thymosin beta4 : structure, function, and biological properties supporting current and future clini- cal applications. Ann N Y Acad Sci ,2010,1194 : 179-189.
  • 3Banerjee I,Zhang J, Moore-Morris T,et al. Thymosin beta 4 is dispen- sable for murine cardiac development and function. Circ Res,2012, 110:456-464.
  • 4Smart N, Dube KN, Riley PR. Identification of Thymosin β4 as an ef- fector of Handl-mediated vascular development. Nat Commun,2010, 1:46.
  • 5Shrivastava S, Srivastava D, Olson EN, et al. Thymosin beta4 and car- diac repair. Ann N Y Acad Sci ,2010,1194:87-96.
  • 6Dube KN,Botlini S, Smart N, et al. Thymosin β4 protein therapy for cardiac repair. Curr Pharm Des,2012,18:799-806.
  • 7Dropulic B. Lentiviral vectors : their molecular design, safety, and use in laboratory and preclinical research. Hum Gene Ther,2011,22 :649- 657.
  • 8Matrai J,Chuah MK,VandenDriessche T. Recent advances in lentiviral vector development and applications. Mol Ther,2010,18:477-490.
  • 9Henry TD, Annex BH, McKendall GR, et al. The VIVA trial : vascular endothelial growth factor in ischemia for vascular angiogenesis. Circu- lation, 2003,107 : 1359 - 1365.
  • 10Schierling W,Troidl K,Troidl C, et al. The role of angiogenic growth factors in arteriogenesis. J Vase Res,2009 ,46 :365-374.

二级参考文献20

  • 1张涛,袁文,刘百峰,曹莉,肖林,陈公星.siRNA干扰大鼠神经元Nogo受体mRNA表达的时程研究[J].中国脊柱脊髓杂志,2005,15(10):588-591. 被引量:13
  • 2吕碧涛,袁文,徐盛明,刘百峰,曹莉.大鼠Nogo受体基因RNA干扰慢病毒载体的构建与鉴定[J].第二军医大学学报,2007,28(1):40-43. 被引量:2
  • 3Woolf CJ,Bloechlinger S.Neuroscience.It takes more than two to Nogo.Science,2002,297:1132-1134.
  • 4Anson DS.The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery.Genet Vaccines Ther,2004,2:9.
  • 5Karolewski BA,Watson DJ,Parente MK,et al.Comparison of transfection conditions for a lentivirus vector produced in large volumes.Hum Gene T her,2003,14:1287-1296.
  • 6Hommel JD,Sears RM,Georgescu D,et al.Local gene knock down in the brain using viral-mediated RNA interference.Nat Med,2003,9:1539-1544.
  • 7Dom G,Patel S,Wotherspoon G,et al.siRNA relieves chronic neuropathic pain.Nucleic Acids Res,2004,32:e49.
  • 8McCaffrey AP,Meuse L,Pham TT,et al.RNA interference in adult mice.Nature,2002,418:38-39.
  • 9Giladi H,Ketzinel-Gilad M,Rivkin L,et al.Small interfering RNA inhibits hepatitis B virus replication in mice.Mol Ther,2003,8:769-776.
  • 10Song E,Lee SK,Wang J,et al.RNA interference targepting Fas protects mice from fulminant hepatitis.Nat Med,2003,9:347-351.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部